Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Therapy Name | HS-201 |
Synonyms | |
Therapy Description |
HS-201 is a conjugate of verteporfin, a photosensitizing agent linked to an inhibitor of heat shock protein 90, which may result in tumor cell killing and inhibition of tumor growth (Cancer Res. 2019, 79(13), Supple. pp. 3731). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
HS-201 | HS201|HS 201 | HS-201 is a conjugate of verteporfin, a photosensitizing agent linked to an inhibitor of heat shock protein 90, which may result in tumor cell killing and inhibition of tumor growth (Cancer Res. 2019, 79(13), Supple. pp. 3731). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT03906643 | Phase I | HS-201 | HS-201, an HSP90 Inhibitor-linked Verteporfin for Detection of Solid Malignancies | Withdrawn | USA | 0 |